Societal impact assessment

Abundance Potential

Infections affected nearly 3 in 10 liver-transplant hospitalizations in a U.S. analysis

Assessment takeaway

Unknown · insufficient evidence

The target is a single nationwide observational analysis. It offers a limited contribution to scientific capability by describing infection burden and associated outcomes, but the packet does not show resulting improvements in wellbeing, affordability, fairness, or environmental sustainability. The supplied source excerpt is bounded and omits its middle; no claims about that omitted material are inferred.

AI-generated · Not editor reviewedAssessed 2026-11-16Rubric abundance-potential-v1

This describes conditional potential, not a probability or measured outcome. Unknown values are not zero, and harms are not subtracted from the total.

Assessment scope

Development
A retrospective nationwide analysis of infection prevalence and associated outcomes in adult liver-transplant hospitalizations using U.S. National Inpatient Sample data from 2016–2022.
Baseline
Clinical and research understanding before this analysis; the packet provides no quantified baseline for its incremental effect on care or health-system outcomes.
Population
Adults hospitalized for liver transplantation; potential knowledge users include clinicians and researchers serving this population.
Geography
United States.
Target assumptions
Potential benefit assumes the findings help frame infection-prevention or risk-assessment research. The analysis does not establish that infections caused worse outcomes or that a particular intervention works.

Five dimensions

Human wellbeing
Unknown · The analysis reports associations with worse hospital outcomes but does not test whether its findings or a resulting intervention improve health. Sources: evidence-2384, evidence-2389
Affordability and access
Unknown · It reports higher adjusted costs for infection-coded hospitalizations, but provides no evidence that the analysis improves affordability or access. Sources: evidence-2385
Reach and fairness
Unknown · The study has national scope, but the supplied evidence does not establish whether benefits reach groups fairly or improve access across groups. Sources: evidence-2387
Environment and resources
Unknown · The study reports hospital stays and costs, but provides no evidence of environmental effects or more sustainable resource use. Sources: evidence-2385
Scientific capability
1/4 · The analysis adds limited descriptive capability by quantifying recorded infections and associated outcomes in a large national sample, and by identifying questions for prospective research. It does not test a prevention strategy or establish actionable causal effects. Sources: evidence-2383, evidence-2387, evidence-2390

Evidence, confidence and timing

Evidence maturity

Finding: Unknown. The packet describes a completed retrospective national analysis, but the maturity categories do not clearly classify this kind of observational finding; no intervention was evaluated.

Societal benefit: Early speculative. The possible societal benefit depends on future use in prevention or risk-assessment research; no resulting improvement in care or outcomes is demonstrated.

Confidence: Low. The study reports a large national sample, but it is retrospective and observational, with unresolved infection timing, missing microbiological details, and possible residual confounding. Its effect on societal abundance is not measured.

Conditional time horizon: Unknown. The packet gives no timeline for translation into practice or resulting benefits; prospective research is identified as a next step.

Possible benefits

  • The national estimates may help researchers and clinicians frame questions about infection prevention and risk assessment for adult liver-transplant hospitalizations. Sources: evidence-2383, evidence-2390

Risks and possible harms

  • Treating the observed associations as causal could lead to misattributed outcomes or poorly targeted prevention and resource decisions. Affected groups: Adult liver-transplant patients, clinicians, and health systems. Sources: evidence-2388, evidence-2389

Distribution and adoption

Who might be excluded

  • The analysis covers adults hospitalized for transplantation; it does not capture pediatric patients or infections occurring outside the hospitalization or after discharge. Sources: evidence-2387, evidence-2388

Adoption barriers

  • The study does not test a prevention strategy, and unavailable infection timing and microbiological details limit how specifically its findings can guide prevention. Sources: evidence-2388, evidence-2390
  • Residual confounding and possible coding limitations make it difficult to infer how much infection itself contributed to the observed outcomes. Sources: evidence-2388, evidence-2389

Assumptions and conditions that could change the assessment

  • A societal benefit assumes that the descriptive findings help guide useful future prevention or risk-assessment research, although the analysis does not establish causal effects or intervention efficacy. Sources: evidence-2389, evidence-2390
  • Prospective studies with microbiological and biochemical data would need to clarify infection types and timing; evidence that a specific strategy improves outcomes or resource use would support a higher benefit assessment. Sources: evidence-2388, evidence-2389, evidence-2390

Citations

  1. evidence-2383 · Burden and impact of infections among adult liver transplantation-related hospitalizations: A nationwide analysis · S; a; h; i; l; j; o; t; ; S; i; n; g; h; ; B; h; u; p; a; l · 10.1371/journal.pone.0363042 · Captured publisher article text · Open source
  2. evidence-2384 · Burden and impact of infections among adult liver transplantation-related hospitalizations: A nationwide analysis · S; a; h; i; l; j; o; t; ; S; i; n; g; h; ; B; h; u; p; a; l · 10.1371/journal.pone.0363042 · Captured publisher article text · Open source
  3. evidence-2385 · Burden and impact of infections among adult liver transplantation-related hospitalizations: A nationwide analysis · S; a; h; i; l; j; o; t; ; S; i; n; g; h; ; B; h; u; p; a; l · 10.1371/journal.pone.0363042 · Captured publisher article text · Open source
  4. evidence-2387 · Burden and impact of infections among adult liver transplantation-related hospitalizations: A nationwide analysis · S; a; h; i; l; j; o; t; ; S; i; n; g; h; ; B; h; u; p; a; l · 10.1371/journal.pone.0363042 · Captured publisher article text · Open source
  5. evidence-2388 · Burden and impact of infections among adult liver transplantation-related hospitalizations: A nationwide analysis · S; a; h; i; l; j; o; t; ; S; i; n; g; h; ; B; h; u; p; a; l · 10.1371/journal.pone.0363042 · Captured publisher article text · Open source
  6. evidence-2389 · Burden and impact of infections among adult liver transplantation-related hospitalizations: A nationwide analysis · S; a; h; i; l; j; o; t; ; S; i; n; g; h; ; B; h; u; p; a; l · 10.1371/journal.pone.0363042 · Captured publisher article text · Open source
  7. evidence-2390 · Burden and impact of infections among adult liver transplantation-related hospitalizations: A nationwide analysis · S; a; h; i; l; j; o; t; ; S; i; n; g; h; ; B; h; u; p; a; l · 10.1371/journal.pone.0363042 · Captured publisher article text · Open source